13F data — long US equity only · ~45-day lag from quarter-end · positions may have changed since · not investment advice
← Strongest buys
0

GEHC

GE HEALTHCARE TECHNOLOGIES I · Health Care

Consensus score 0/100 · #327 this quarter · tier-weighted across tracked managers

NeutralPrice action since filingas of 2026-06-05
vs 50-day avg
-3.0%
21-day momentum
+4.8%
recent volume
0.95×

13F filings lag ~45 days; this is current price/volume action on top — a technical read, not a prediction.

S4· DecliningStage Analysis · Weinstein
vs 30-wk avg
-13.9%
30-wk MA slope
-2.3%
rel. strength
-20.4
52-wk range
19%

Declining — below a falling 30-week trend, lagging the market. Weinstein says avoid. Based on the 30-week (150-day) moving average + slope, Mansfield relative strength vs SPY, and volume. Technical read, not advice.

Holders
4
tracked managers
New this Q
0
opened a position
Avg weight
0.0%
of their portfolios
Combined value
$2M
held, at quarter-end

Who’s holding it Q1 2026, by position size

ManagerPosition sizeChange
Semper Augustus
Concentrated
0.0%
HOLD
Trian Partners
Concentrated
0.0%
HOLD
Eagle Capital
Quality value
0.0%
HOLD
Horizon Kinetics
Franchise/inflation
0.0%
HOLD

Position size = share of that manager’s reported long US-equity portfolio. The consensus score weights each holder by quality tier, position size, and whether they were buying or trimming — then discounts very crowded names. It measures agreement among these managers, not expected return.